Page last updated: 2024-10-24

celecoxib and Contracture

celecoxib has been researched along with Contracture in 3 studies

Contracture: Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2 mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the effectiveness of oral administration of non-steroidal anti-inflammatory drug celecoxib (CBX) for the prevention of myogenic and arthrogenic contracture following immobilization in a rat model."7.83Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. ( Kaneguchi, A; Kito, N; Moriyama, H; Ozawa, J; Tanaka, R, 2016)
" The purpose of this study was to use a validated rabbit model to assess the effects on surgically-induced knee joint contractures of two combined pharmacological interventions: celecoxib (CXB) loaded on an implanted collagen membrane, and subcutaneously (SQ) injected ketotifen."3.96Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen. ( Abdel, MP; Berry, CE; Berry, DJ; Bolon, B; Carter, JM; Jay, AG; Limberg, AK; McLaury, AR; Morrey, ME; Salib, CG; Sanchez-Sotelo, J; Tibbo, ME; Turner, TW; van Wijnen, AJ, 2020)
"The aim of this study is to clarify the following two points: First, whether a cyclooxygenase-2 mediated pathway is involved in the formation of immobilization-induced joint contracture and, second, the effectiveness of oral administration of non-steroidal anti-inflammatory drug celecoxib (CBX) for the prevention of myogenic and arthrogenic contracture following immobilization in a rat model."3.83Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees. ( Kaneguchi, A; Kito, N; Moriyama, H; Ozawa, J; Tanaka, R, 2016)
"Arthrofibrosis is a common complication following total knee arthroplasty caused by pathologic fibroblast activation and excessive collagen deposition around a synovial joint leading to debilitating loss of motion."1.51Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture. ( Abdel, MP; Berry, DJ; Bolon, B; Carter, JM; Jay, AG; Jones, CR; Lewallen, EA; Limberg, AK; Morrey, ME; Paradise, CR; Reina, N; Robin, JX; Salib, CG; Sanchez-Sotelo, J; Tibbo, ME; Trousdale, WH; Turner, TW; van Wijnen, AJ, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Salib, CG2
Reina, N1
Trousdale, WH1
Limberg, AK2
Tibbo, ME2
Jay, AG2
Robin, JX1
Turner, TW2
Jones, CR1
Paradise, CR1
Lewallen, EA1
Bolon, B2
Carter, JM2
Berry, DJ2
Morrey, ME2
Sanchez-Sotelo, J2
van Wijnen, AJ2
Abdel, MP2
McLaury, AR1
Berry, CE1
Ozawa, J1
Kaneguchi, A1
Tanaka, R1
Kito, N1
Moriyama, H1

Other Studies

3 other studies available for celecoxib and Contracture

ArticleYear
Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2019, Volume: 37, Issue:12

    Topics: Animals; Arthroplasty, Replacement, Knee; Biomechanical Phenomena; Celecoxib; Collagen; Contracture;

2019
Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020, Volume: 38, Issue:11

    Topics: Animals; Celecoxib; Contracture; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Delivery

2020
Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees.
    BMC musculoskeletal disorders, 2016, 10-24, Volume: 17, Issue:1

    Topics: Administration, Oral; Animals; Arthritis; Celecoxib; Contracture; Cyclooxygenase 2; Cyclooxygenase 2

2016